NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080221237

Registered date:10/09/2010

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedType 2 diabetes mellitus with renal dysfunction
Date of first enrollment10/09/2010
Target sample size50
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : TS-071 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 79age old
GenderBoth
Include criteria- Japanese - Type 2 diabetes mellitus patient etc.
Exclude criteria- Non-type 2 diabetes mellitus - Having critical heart disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease etc.

Related Information

Contact

Public contact
Name
Address Clinical-trials@po.rd.taisho.co.jp
Telephone
E-mail
Affiliation Taisho Pharmaceutical co., LTD
Scientific contact
Name
Address Clinical-trials@po.rd.taisho.co.jp
Telephone
E-mail
Affiliation Taisho Pharmaceutical co., LTD